Recruiting now—Ages 18 Years and up
PROMIS and Mobility Evaluation in Sarcoma Patients
Sponsor: University of Calgary · NCT07227961 on ClinicalTrials.gov ↗
Conditions studied
SarcomaGiant Cell Tumor of Bone
What it tests
- Surgeryprocedure
Where it's running4 sites
- Opening soon
Mayo Clinic
Phoenix, Arizona 85054
- Krista A Goulding, MD MPH(contact)480-342-2407[email protected]
- Ray Canez, BS(contact)480-574-2753[email protected]
- Krista A Goulding, MD MPH(principal investigator)
- Opening soon
Mayo Clinic
Rochester, Minnesota 55905
- Matthew T Houdek, MD(contact)507-284-2995[email protected]
- Matthew T Houdek, MD(principal investigator)
2 international sites
- Recruiting now
Foothills Medical Centre, Arthur J Child Comprehensive Cancer Centre, University of Calgary
Calgary, Alberta, Canada T2N 2T9
- Joseph K Kendal, MD MSc FRCSC(contact)403-944-4793[email protected]
- Alyssa A Federico, MD(contact)403-650-5071[email protected]
- Joseph K Kendal, MD MSc FRCSC(principal investigator)
- Michael J Monument, MD MSc FRCSC(sub investigator)
- Shannon Puloski, MD FRCSC(sub investigator)
- Opening soon
Mount Sinai Hospital, University of Toronto
Toronto, Ontario, Canada M5G 1X5
- Jay S Wunder, MD MSc FRCSC(contact)416-586-4800[email protected]
- Anthony Griffin, MSc(contact)416-586-4800[email protected]
- Jay S Wunder, MD MSc FRCSC(principal investigator)
- Peter C Ferguson, MD MSc FRCSC FAOA(sub investigator)
- Aaron M Gazendam, MD MSc FRCSC(sub investigator)
- Kim Tsoi, MD PhD FRCSC(sub investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of bone sarcoma, soft tissue sarcoma, or giant cell tumor of bone * Tumors located in the pelvis, lower extremities, or upper extremities * Primary or recurrent disease * Undergoing operative tumor resection, including limb salvage surgery and amputation * Has an iPhone or Android phone * Speaks English Exclusion Criteria: * Metastatic bone tumor * Diagnosis of atypical lipomatous tumor or dermatofibrosarcoma protuberans * Currently pregnant or planning pregnancy within 6 months * Unwilling or unable to attend follow-up evaluations * Cognitive or communication barriers that impede completion of questionnaires
Updated 2025-11-13 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.